US rejects WHO global pandemic response accord

The United States has rejected an agreement adopted by members of the World Health Organisation to improve preparedness for future pandemics following the disjointed global response to Covid-19, the American government said on Friday.

The State Department and Department of Health and Human Services said in a statement they had transmitted on Friday the official US rejection of the legally binding pact, which was adopted in Geneva in May after three years of negotiations.

The pact aims to ensure that drugs, therapeutics and vaccines are globally accessible when the next pandemic hits. It requires participating manufacturers to allocate a target of 20 per cent of their vaccines, medicines and tests to the WHO during a pandemic to ensure poorer countries have access.

US negotiators left discussions about the accord after President Donald Trump began a 12-month process of withdrawing the US, by far the WHO’s largest financial backer, from the agency when he took office in January. Its exit means the US would not be bound by the pact.

“Developed without adequate public input, these amendments expand the role of the WHO in public health emergencies, create additional authorities for the WHO for shaping pandemic declarations, and promote the WHO’s ability to facilitate ‘equitable access’ of health commodities,” the US statement said.

“Terminology throughout the 2024 amendments is vague and broad, risking WHO-coordinated international responses that focus on political issues like solidarity, rather than rapid and effective actions,” said the statement, jointly issued by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F Kennedy Jr.

Kennedy, who has a long history of sowing doubt about vaccine safety, had slammed WHO in a video address to the Assembly during its vote, saying it had failed to learn from the lessons of the pandemic with the new agreement.

Kennedy and Rubio said on Friday that the rejection protects US sovereignty. The pact leaves health policy to national governments and contains nothing that overrides national sovereignty, however.

Read More

Latest

Sleater-Kinney and Liz Phair Unite for Co-Headlining Tour

Music Sleater-Kinney and Liz Phair are hitting the road...

Foodies! Get Ready to Feast at GTCO Food and Drink Festival 2026

Music Food lovers, it is almost that time again....

Shazmicsoul – Next 2 U Ft Floyd Rhythmic

MusicDOWNLOAD MP3 SONG...

Newsletter

Don't miss

Sleater-Kinney and Liz Phair Unite for Co-Headlining Tour

Music Sleater-Kinney and Liz Phair are hitting the road...

Foodies! Get Ready to Feast at GTCO Food and Drink Festival 2026

Music Food lovers, it is almost that time again....

Shazmicsoul – Next 2 U Ft Floyd Rhythmic

MusicDOWNLOAD MP3 SONG...

“Fame Has Downsides” – Davido Opens Up on Painful Family Struggles

MusicDavido has spoken about the negative side of...

Jury acquits 2 business executives of bribing Navy admiral for government contract

A federal jury has acquitted two business executives of charges that they conspired to bribe a retired four-star U.S. Navy admiral, who is now serving a six-year prison sentence for his conviction on corruption charges By MICHAEL KUNZELMAN Associated Press WASHINGTON -- A federal jury has acquitted two business executives of charges that they conspired

US Business Leaders Optimistic About China Cooperation, Emphasize Importance of Chinese Market

© 2026 China Money Network. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.

Tesla’s Business Has Become Much More Diversified in Just the Past Five Years. Does That Make Its Stock a Better Buy Today?

Key Points Tesla's energy generation and storage segment generated 27% revenue growth last year. The company's non-automotive segments were able to help offset a double-digit decline in auto revenue in 2025. These 10 stocks could mint the next wave of millionaires › Tesla (NASDAQ: TSLA) is known for its electric vehicles (EVs), and while they